Here are relevant reports on : human-capital-management-hcm-market
-
Dark Analytics Market by Component (Solutions, Services), Deployment Mode (Cloud, On-premises), Business Application (Marketing, Operations, Finance, Human Resources), Vertical (BFSI, Healthcare), and Region - Global Forecast to 2023
The dark analytics market is expected to grow from USD 278.3 million in 2018 to USD 867.7 million by 2023, at a CAGR of 25.5% from 2018 to 2023. The dark analytics market is projected to witness significant growth during the forecast period, majorly driven by the rapid increase in data generated by organizations, the adoption of artificial intelligence, and machine learning technologies for dark data analysis, and increase in the deployment of dark analytics solutions. Increasing investments in dark analytics technology by SMEs is one of the opportunities for growth in the dark analytics market. Dark analytics helps organizations in managing campaigns, making quick decisions, analyzing markets, and deriving customer insights. Dark analytics empowers the decision-making process of SMEs and enable them to easily identify existing and future business risks. The major vendors covered in the dark analytics market include IBM (US), SAP (Germany), Amazon Web Services (US), Micro Focus (UK), Dell EMC (US), Microsoft (US), AvePoint (US), Teradata (US), Symantec (US), Datameer (US), IRI (US), SAS (US), Commvault (US), Veritas (US), Cohesity (US), Datumize (Spain), SynerScope (Netherlands), Komprise (US), Lattice (US), Quantta Analytics (India), Zoomdata (US), Formcept (India), Globanet (US), Esdebe Consultancy (UK), and Levi, Ray & Shoup (US).
- Published: July 2018
- Price: $ 4950
- TOC Available:
-
Probiotic Ingredients Market by Application (Functional Foods & Beverages, Pharmaceuticals, and Animal Nutrition), Source (Bacteria and Yeast), Form (Dry and Liquid), End User (Human and Animal), and Region - Global Forecast to 2023
The probiotic ingredients market is projected to grow from USD 268 million in 2018 to USD 402 million by 2023, at a compound annual growth rate (CAGR) of 8.5% during the forecast period. The increasing demand for dietary supplements in the pharmaceuticals, cosmetics, and personal care industries is projected to drive the market for probiotics, which in turn, is projected to drive the market growth for probiotic ingredients.
- Published: December 2018
- Price: $ 4950
- TOC Available:
-
Global Albumin Market, by Product (Human Serum Albumin, Bovine Albumin, Recombinant Serum Albumin) by Application (Therapeutic, Drug Delivery, Culture Media, Vaccine Ingredient) by Region - Forecast to 2022
The global albumin market is projected to grow at a CAGR of around 6% during the forecast period (2017-2022). Factors such as the high demand of albumin in R&D activities, rising non-therapeutic application of albumin, development of plant based albumin, rising production of immunoglobulins, and rise in plasma collection are driving the market. However, the stringent regulations, limited reimbursement, and irrational uses and adverse effects associated with albumin are the factors restraining the growth of this market.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Data Lake Market by Component, Deployment Mode, Organization Size, Business Function (Marketing, Operations, and Human Resources), Industry Vertical (BFSI, Healthcare and Life Sciences, Manufacturing), and Region - Global Forecast to 2024
The data lake market is expected to grow from USD 7.9 billion in 2019 to USD 20.1 billion by 2024, at a compound annual growth rate (CAGR) of 20.6% during the forecast period.Major vendors in the global data lake market include Microsoft (US), Teradata (US), Oracle (US), Cloudera (US), AWS (US), IBM (US), Informatica (US), SAS Institute (US), Zaloni (US), Koverse (US), HPE (US), Cazena (US), Google (US), Infoworks.io (US), Snowflake (US), and Dremio (US). These vendors have adopted various organic and inorganic growth strategies, such as new product launches, partnerships and collaborations, and mergers and acquisitions, to expand their presence in the global data lake market.
- Published: January 2020
- Price: $ 4950
- TOC Available:
-
Probiotics Market Report by Product Type (Functional Food & Beverages (FnB), Dietary Supplements, and Feed), Ingredient (Bacteria and Yeast), End User (Human and Animal), Distribution Channel, and Region - Global Forecast to 2030
The global probiotics market is estimated to be valued at USD 76.59 billion in 2025 and is projected to reach USD 114.95 billion by 2030, growing at a CAGR of 8.5% from 2025 to 2030. Key players in this market include Probi (Sweden), Nestlé (Switzerland), ADM (US), Danone (France), International Flavors & Fragrances Inc. (US), Yakult Honsha Co., Ltd. (Japan), BioGaia (Sweden), MORINAGA MILK INDUSTRY CO., LTD. (Japan), Meiji Holdings Co., Ltd. (Japan), Lifeway Foods, Inc. (US), Adisseo (France), Winclove Probiotics (US), AB-Biotics, S.A. (Belgium), Apsen Farmacêutica (Brazil), and Lallemand (Canada).
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Nutrigenomics Market: A boon to Human Health, Perspective by Applications and Geography - Global Trends and Forecasts up to 2017
As a result of globalization, the global population is being more health conscious. The ever increasing middleclass families also prefer the healthy diet and are more concerned towards nutrition. Thus the pioneering concept of Nutrigenomics has been boon for human health which provides a customized food which helps in optimum utilization of nutrients.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Cell Viability Assays Market by Product (MTT Assay, XTT Assay, Calcein, Resazurin, Flow Cytometry, Spectrophotometer), Cell Type (Human, Animal, Microbial), Application (Basic Research, Stem Cell, Discovery & Development) - Global Forecast to 2023
The global cell viability assays market is projected to reach USD 4.16 billion by 2023, growing at a CAGR of 8.4%. The prominent players in the cell viability assays market are Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Merck (Germany), GE Healthcare (US), BioTek Instruments (US), PerkinElmer (US), Promega Corporation (US), Biotium (US), Abcam plc (UK), Canvax (Spain), Abnova (Taiwan), G-Biosciences (US), Creative Bioarray (US), Danaher Corporation (US), and Becton, Dickinson and Company (US).
- Published: September 2018
- Price: $ 4950
- TOC Available:
-
Europe Probiotics Market by Product Type (Functional Food & Beverages, Dietary Supplements, and Feed), Ingredient (Bacteria and Yeast), End User (Human and Animal), Distribution Channel, and Region - Forecast to 2030
The Europe probiotics market is estimated to be USD 15.73 billion in 2025 and is projected to reach USD 20.56 billion by 2030, registering at a CAGR of 5.5% from 2025 to 2030. The key players such as Danone S.A. (France), Probi AB (Sweden), Nestlé S.A. (Switzerland), Kerry Group plc (Ireland), BioGaia AB (Sweden), Bio-K Plus International Inc. (Canada), Daflorn Probiotics Ltd. (Bulgaria), Yakult Honsha Co., Ltd. (Japan), Arla Foods (Denmark), and AB-Biotics S.A. (Spain).
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Human Microbiome Market by Drug & Supplement (Drugs, Probiotics, Prebiotics), Disease (Infectious, Gastrointestinal, Endocrine & Metabolic Diseases), Type (BCT/FMT, LBP), End User (Hospitals, Clinics, Long-term Care) - Forecast to 2031
The Asia Pacific Human Microbiome Market, valued at US$0.19 billion in 2024, stood at US$0.26 billion in 2025 and is projected to advance at a resilient CAGR of 31.0% from 2025 to 2031, culminating in a forecasted valuation of US$1.31 billion by the end of the period. Market growth is driven by an increasing focus on preventive and personalized health, rising adoption of microbiome-based diagnostics and therapeutic solutions, and rapid advances in next-generation sequencing, AI-enabled microbiome analytics, and regional bioinformatics capabilities.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Primary Cells Market by Type (Hematopoietic, Dermatocytes, Hepatocytes, Gastrointestinal, Lung, Renal, Heart, Musculoskeletal), Origin (Human Primary Cells, Animal Primary Cells), End User (Pharma Biotech, CROs, Academia), Region - Global Forecast to 2028
The global primary cells market, valued at US$1.5 billion in 2022, stood at US$1.7 billion in 2023 and is projected to advance at a resilient CAGR of 10.5% from 2023 to 2028, culminating in a forecasted valuation of US$2.8 billion by the end of the period. The growth of this market can be attributed to factors such as the is the growing advantages of primary human cells over cell lines, rising growth in pharmaceutical & biotechnology industries, increasing demand for monoclonal antibodies, Government investments for cell-based research, and increasing cancer research.
- Published: July 2023
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
